These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 7876525)
1. Sulfasalazine, 5-ASA and acute pancreatitis in crohn's disease. Debongnie JC; Dekoninck X J Clin Gastroenterol; 1994 Dec; 19(4):348-9. PubMed ID: 7876525 [No Abstract] [Full Text] [Related]
2. Acute pancreatitis in Crohn's disease due to 5-ASA therapy. Radke M; Bartolomaeus G; Müller M; Richter I J Pediatr Gastroenterol Nutr; 1993 Apr; 16(3):337-9. PubMed ID: 8492268 [No Abstract] [Full Text] [Related]
3. [Acute pancreatitis due to 5-aminosalicylic acid]. Romero Castro R; Jiménez Sáenz M; Pellicer Bautista FJ; Domínguez Palomo S; Herrerías Gutiérrez JM Rev Esp Enferm Dig; 1991 Mar; 79(3):219-21. PubMed ID: 2043409 [TBL] [Abstract][Full Text] [Related]
4. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions]. Uittenbogaart SB; Klemt-Kropp M Ned Tijdschr Geneeskd; 2011; 155(48):A3842. PubMed ID: 22152414 [TBL] [Abstract][Full Text] [Related]
5. [Acute renal failure associated with 5-aminosalicylic acid in inflammatory bowel disease]. García-Díaz M; Nevado L; Berenguer A; Bureo JC; Bureo P; Sáenz de Santamaría J Gastroenterol Hepatol; 1995 Jan; 18(1):18-21. PubMed ID: 7621266 [TBL] [Abstract][Full Text] [Related]
6. 5-Aminosalicylic acid-associated renal tubular acidosis with decreased renal function in Crohn's disease. Hämling J; Raedler A; Helmchen U; Schreiber S Digestion; 1997; 58(3):304-7. PubMed ID: 9243128 [TBL] [Abstract][Full Text] [Related]
8. [Hypersensitivity to 5-aminosalicylic acid. Value of desensitization by oral route]. Lachaux A; Le Gall C; Loras-Duclaux I; Aboufadel A; Hermier M Arch Pediatr; 1997 Feb; 4(2):144-6. PubMed ID: 9097825 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study. Munk EM; Pedersen L; Floyd A; Nørgård B; Rasmussen HH; Sørensen HT Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355 [TBL] [Abstract][Full Text] [Related]
11. Cholestasis associated with mesalazine therapy in a patient with Crohn's disease. Stoschus B; Meybehm M; Spengler U; Scheurlen C; Sauerbruch T J Hepatol; 1997 Feb; 26(2):425-8. PubMed ID: 9059966 [TBL] [Abstract][Full Text] [Related]
12. [Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine]. Glintborg B Ugeskr Laeger; 2000 Aug; 162(34):4553-4. PubMed ID: 10981226 [TBL] [Abstract][Full Text] [Related]
13. Pancreatitis in inflammatory bowel diseases. Pitchumoni CS; Rubin A; Das K J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199 [TBL] [Abstract][Full Text] [Related]
14. Acute pancreatitis during oral 5-aminosalicylic acid therapy. Fiorentini MT; Fracchia M; Galatola G; Barlotta A; de la Pierre M Dig Dis Sci; 1990 Sep; 35(9):1180-2. PubMed ID: 2390934 [TBL] [Abstract][Full Text] [Related]
15. [Mesalazine]. Netzer P Dtsch Med Wochenschr; 1996 Jan; 121(1-2):42. PubMed ID: 8565806 [No Abstract] [Full Text] [Related]